K
Kirstin Mösbauer
Researcher at Charité
Publications - 8
Citations - 933
Kirstin Mösbauer is an academic researcher from Charité. The author has contributed to research in topics: Viral replication & Virus. The author has an hindex of 5, co-authored 7 publications receiving 578 citations. Previous affiliations of Kirstin Mösbauer include Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
Markus Hoffmann,Markus Hoffmann,Kirstin Mösbauer,Kirstin Mösbauer,Heike Hofmann-Winkler,Artur Kaul,Hannah Kleine-Weber,Hannah Kleine-Weber,Nadine Krüger,Nils C. Gassen,Marcel A. Müller,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann,Stefan Pöhlmann +15 more
TL;DR: The results indicate that chloroquine targets a pathway for viral activation that is not active in lung cells and is unlikely to protect against the spread of SARS-CoV-2 in and between patients.
Journal ArticleDOI
SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection
Nils C. Gassen,Daniela Niemeyer,Doreen Muth,Victor M. Corman,Silvia Martinelli,Alwine Gassen,Kathrin Hafner,Jan Papies,Kirstin Mösbauer,Andreas Zellner,Anthony S. Zannas,Alexander M. Herrmann,Florian Holsboer,Ruth Brack-Werner,Michael Boshart,Bertram Müller-Myhsok,Bertram Müller-Myhsok,Christian Drosten,Marcel A. Müller,Theo Rein,Theo Rein +20 more
TL;DR: It is shown that S-phase kinase-associated protein 2 (SKP2) is responsible for lysine-48-linked poly-ubiquitination of beclin 1, resulting in its proteasomal degradation, and that inhibition of SKP2 enhances autophagy and reduces replication of MERS coronavirus.
Journal ArticleDOI
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.
Emanuel Wyler,Kirstin Mösbauer,Vedran Franke,Asija Diag,Lina Theresa Gottula,Roberto Arsie,Filippos Klironomos,Filippos Klironomos,David Koppstein,Katja Hönzke,Salah Ayoub,Christopher Buccitelli,Karen Hoffmann,Anja Richter,Ivano Legnini,Andranik Ivanov,Tommaso Mari,Simone Del Giudice,Jan Papies,Samantha D. Praktiknjo,Thomas F. Meyer,Marcel A. Müller,Daniela Niemeyer,Andreas C. Hocke,Matthias Selbach,Altuna Akalin,Nikolaus Rajewsky,Christian Drosten,Markus Landthaler,Markus Landthaler +29 more
TL;DR: In this article, gene expression profiles of three SARS-CoV and SARS CoV-2 infected human cell lines were reported, and it was shown that SARS co-virus infection elicited an approximately two-fold higher stimulation of the innate immune response compared to SARS in the human epithelial cell line Calu-3, including induction of miRNA-155.
Posted ContentDOI
Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention
Emanuel Wyler,Kirstin Mösbauer,Vedran Franke,Asija Diag,Lina Theresa Gottula,Roberto Arsie,Filippos Klironomos,David Koppstein,Salah Ayoub,Christopher Buccitelli,Anja Richter,Ivano Legnini,Andranik Ivanov,Tommaso Mari,Simone Del Giudice,Jan Papies,Marcel A. Müller,Daniela Niemeyer,Matthias Selbach,Altuna Akalin,Nikolaus Rajewsky,Christian Drosten,Markus Landthaler +22 more
TL;DR: In vitro cell culture models are established to study SARS-CoV-2 infection and heat shock protein 90 (HSP90) protein is identified as a potential drug target for therapeutic intervention of Sars-CoVs infection.
Journal ArticleDOI
The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species.
Daniela Niemeyer,Kirstin Mösbauer,E. Klein,Andrea Sieberg,Andrea Sieberg,Robert C. Mettelman,Anna M. Mielech,Ronald Dijkman,Susan C. Baker,Christian Drosten,Christian Drosten,Christian Drosten,Marcel A. Müller,Marcel A. Müller,Marcel A. Müller +14 more
TL;DR: The results of this study revealed that coronavirus PLP confers a variable virulence trait among members of the species SARS-CoV, and that a Sars- coV lineage with virulent PLPs may have pre-existed in the reservoir before onset of the epidemic.